Browse Category

Stocks News 12 January 2026

Carvana stock ticks up near $470 as Wall Street waits on CPI and rate signals

Carvana stock ticks up near $470 as Wall Street waits on CPI and rate signals

New York, January 12, 2026, 13:30 EST — The regular session is underway. Carvana Co. shares rose Monday, extending a strong start to the year that has kept the online used-car retailer close to its recent peaks. The stock gained 1.6%, settling at $470.52 after swinging between $455.32 and $470.92 during the session. The gain arrived after the broader market…
GE Vernova (GEV) stock jumps as GLJ lifts target to $1,087; Baird turns cautious on competition

GE Vernova (GEV) stock jumps as GLJ lifts target to $1,087; Baird turns cautious on competition

New York, Jan 12, 2026, 12:29 EST — Regular session Shares of GE Vernova Inc. climbed Monday after GLJ Research raised its price target to $1,087 from $805. Meanwhile, Baird downgraded the stock to Hold, cutting its target to $649. The stock was up 2.7% at $639.38 by midday, fluctuating between $614.33 and $644.73 earlier. Baird cited increasing competition from…
IREN stock jumps as bitcoin firms up; what traders are watching next

IREN stock jumps as bitcoin firms up; what traders are watching next

New York, Jan 12, 2026, 11:15 EST — Regular session underway. IREN Limited shares jumped Monday, gaining roughly 7.3% to $49.38 as buyers returned to crypto-linked stocks. Early trading saw the price fluctuate between $45.85 and $49.83, with roughly 20.5 million shares changing hands. The move is significant because IREN straddles two worlds: it continues mining bitcoin while also positioning…
Netflix stock rises as Paramount lawsuit turns up heat on Warner deal, HSBC starts with Buy

Netflix stock rises as Paramount lawsuit turns up heat on Warner deal, HSBC starts with Buy

New York, Jan 12, 2026, 10:20 EST — Regular session Netflix shares ticked up Monday, even as Paramount Skydance ramped up its opposition to Netflix’s bid for major Warner Bros. Discovery assets, injecting fresh doubt into the deal’s outlook. The clash comes right before Netflix’s quarterly earnings next week, with investors eager for updates on the company’s outlook and the…
Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms

Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms

New York, Jan 12, 2026, 10:18 (ET) — Regular session Klarna Group plc shares dropped 4.8% to $29.96 in early Monday trading, down from an opening price of $32.33, as investors digested new policy risks tied to U.S. consumer lending and increased legal scrutiny on the recently listed fintech. (Investing) The shift follows U.S. President Donald Trump’s proposal to cap…
Moderna (MRNA) stock slips after $1.9B 2025 revenue view and cost cuts — what to watch next

Moderna (MRNA) stock slips after $1.9B 2025 revenue view and cost cuts — what to watch next

New York, January 12, 2026, 09:55 EST — Regular session Moderna (MRNA.O) shares dropped about 2% to $33.60 early Monday after the biotech forecasted around $1.9 billion in revenue for 2025 and lowered its GAAP operating-expense forecast for that year—the U.S. accounting standard. The stock swung between $35.77 and $33.33 in a volatile session. (ACCESS Newswire) This update is crucial…
Nvidia stock slips early as traders eye China chip demand, TSMC outlook and CPI

Nvidia stock slips early as traders eye China chip demand, TSMC outlook and CPI

New York, Jan 12, 2026, 09:34 EST — Regular session Nvidia (NVDA.O) shares dipped slightly in early Monday trading, falling around 0.1% to $184.86. The drop followed a slip in U.S. futures as investors remained wary of big-cap growth stocks. Timing is critical. This week packs a heavy slate of macro data and earnings reports, and traders have quickly sold…
Mereo BioPharma stock steadies premarket as JPM Healthcare Conference puts MREO back in play

Mereo BioPharma stock steadies premarket as JPM Healthcare Conference puts MREO back in play

New York, January 12, 2026, 05:24 EST — Premarket Mereo BioPharma Group plc shares held steady near $0.49 in U.S. premarket trading Monday, following a strong 28.6% jump to $0.4944 at Friday’s close. (The Wall Street Journal) Timing is key here. The J.P. Morgan Healthcare Conference is set for Jan. 12-15 in San Francisco, a week known for sharp moves…
12 January 2026
Diageo shares rise as Kenya court keeps $2.3bn Asahi deal moving

Diageo shares rise as Kenya court keeps $2.3bn Asahi deal moving

London, Jan 12, 2026, 08:20 GMT — Regular session Diageo shares ticked higher Monday following a Kenyan High Court ruling that permitted regulatory approval procedures to proceed for the spirits giant’s planned sale of its East African beer unit to Japan’s Asahi. However, the court put a hold on the deal’s final steps. (MarketScreener UK) This deal is key because…
12 January 2026
UOB stock nudges higher as dividend hunt and rate outlook keep Singapore banks in play

UOB stock nudges higher as dividend hunt and rate outlook keep Singapore banks in play

Singapore, January 12, 2026, 15:03 SGT — Regular session Shares of United Overseas Bank Limited (U11) rose 0.14 Singapore dollars, or about 0.4%, to S$36.16 in Monday afternoon trade. DBS Group and OCBC were also firmer, up 0.5% and 1.1% respectively, Google Finance data showed. (Google) The move comes as Singapore bank stocks start 2026 on the front foot, with…
1 11 12 13 14 15 89

Stock Market Today

  • Duolingo (DUOL) Valuation Under Scrutiny After Recent Decline and Mixed P/E, DCF Signals
    January 21, 2026, 6:15 PM EST. Duolingo's (DUOL) shares have fallen roughly 52% over three months despite a 74% positive three-year return. Currently priced at $148.58, the stock trades at a P/E ratio of 17.8x, below peers' 28.3x but above the Consumer Services sector average of 16.9x, indicating mixed investor sentiment. Its discounted cash flow (DCF) model suggests a much higher intrinsic value of $456.95, pointing to potential undervaluation. However, risks include a recent 18% decline in net income and possible shifts in sector valuation multiples. Investors face a dilemma between the P/E-based overvaluation and DCF-based undervaluation signals while deciding on Duolingo's outlook amid weakening share momentum.
Go toTop